Literature DB >> 22002509

Studies in insulin resistance following very low calorie diet and/or gastric bypass surgery.

Jonathan Foo1, Jeremy Krebs, Mark Thomas Hayes, Damon Bell, Donia Macartney-Coxson, Tony Croft, Richard Strawson Stubbs.   

Abstract

The explanation for the rapid improvement in insulin resistance after Roux-en Y gastric bypass (RYGB) may involve mechanisms additional to caloric restriction and improvements in peripheral glucose disposal. 8 severely obese patients underwent a 6-day very low calorie diet (VLCD) (456 kcal/day) followed 1-3 weeks later by RYGB. Insulin resistance was measured by short intravenous insulin tolerance test (IVITT) and by homeostasis model assessment (HOMA) before and again 6 days after the VLCD and after RYGB. In a group of 24 matched patients, HOMA assessments were made before and six days after RYGB. HOMA-IR fell significantly from 6.84.9 to 4.32.9 (p < 0.05) following VLCD, but this was less than the subsequent fall following RYGB (6.8 ± 4.9 to 1.50.4, p < 0.01). Control patients who underwent RYGB alone, reduced their HOMA-IR to 1.50.9 following the operation which was not significantly different from the VLCD then RYGB group. Following VLCD, IVITT showed no significant change. However, 6 days after RYGB, IVITT showed worsened insulin induced glucose uptake (p < 0.05). Patients undergoing VLCD over six days had a reduction in HOMA-IR which was half that of patients undergoing RYGB. Patients who underwent both VLCD and RYGB had a total reduction in HOMA similar to those who underwent the RYGB alone. In contrast, IVITT showed a worsening in insulin induced glucose disposal following RYGB, which suggests worsening peripheral insulin resistance. This study supports the hypothesis that mechanisms other than caloric restriction are involved in the acute improvement in HOMA-IR following RYGB.

Entities:  

Mesh:

Year:  2011        PMID: 22002509     DOI: 10.1007/s11695-011-0527-6

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  36 in total

Review 1.  Insulin resistance: a marker of surgical stress.

Authors:  A Thorell; J Nygren; O Ljungqvist
Journal:  Curr Opin Clin Nutr Metab Care       Date:  1999-01       Impact factor: 4.294

2.  The surgical technique of the Fobi-Pouch operation for obesity (the transected silastic vertical gastric bypass).

Authors:  M A Fobi; H Lee
Journal:  Obes Surg       Date:  1998-06       Impact factor: 4.129

3.  Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study.

Authors:  Kusal Wickremesekera; Geoff Miller; Tissa Desilva Naotunne; Graham Knowles; Richard S Stubbs
Journal:  Obes Surg       Date:  2005-04       Impact factor: 4.129

4.  Twenty-four hour insulin secretion and beta cell NEFA oxidation in type 2 diabetic, morbidly obese patients before and after bariatric surgery.

Authors:  S Salinari; A Bertuzzi; A Iaconelli; M Manco; G Mingrone
Journal:  Diabetologia       Date:  2008-05-06       Impact factor: 10.122

5.  The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery.

Authors:  James M Isbell; Robyn A Tamboli; Erik N Hansen; Jabbar Saliba; Julia P Dunn; Sharon E Phillips; Pamela A Marks-Shulman; Naji N Abumrad
Journal:  Diabetes Care       Date:  2010-04-05       Impact factor: 19.112

Review 6.  Benefits and limitations of very-low-calorie diet therapy in obese NIDDM.

Authors:  R R Henry; B Gumbiner
Journal:  Diabetes Care       Date:  1991-09       Impact factor: 19.112

7.  Metabolic consequences of very-low-calorie diet therapy in obese non-insulin-dependent diabetic and nondiabetic subjects.

Authors:  R R Henry; T A Wiest-Kent; L Scheaffer; O G Kolterman; J M Olefsky
Journal:  Diabetes       Date:  1986-02       Impact factor: 9.461

8.  Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters.

Authors:  Carel W le Roux; Simon J B Aylwin; Rachel L Batterham; Cynthia M Borg; Frances Coyle; Vyas Prasad; Sandra Shurey; Mohammad A Ghatei; Ameet G Patel; Stephen R Bloom
Journal:  Ann Surg       Date:  2006-01       Impact factor: 12.969

9.  First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery.

Authors:  Serenella Salinari; Alessandro Bertuzzi; Simone Asnaghi; Caterina Guidone; Melania Manco; Geltrude Mingrone
Journal:  Diabetes Care       Date:  2008-11-25       Impact factor: 19.112

Review 10.  Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes.

Authors:  Ele Ferrannini; Geltrude Mingrone
Journal:  Diabetes Care       Date:  2009-03       Impact factor: 19.112

View more
  15 in total

Review 1.  Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.

Authors:  C Dirksen; N B Jørgensen; K N Bojsen-Møller; S H Jacobsen; D L Hansen; D Worm; J J Holst; S Madsbad
Journal:  Diabetologia       Date:  2012-04-27       Impact factor: 10.122

2.  Sleeve gastrectomy rapidly enhances islet function independently of body weight.

Authors:  Jonathan D Douros; Jingjing Niu; Sophia Sdao; Trillian Gregg; Kelsey Fisher-Wellman; Manish Bharadwaj; Anthony Molina; Ramamani Arumugam; MacKenzie Martin; Enrico Petretto; Matthew J Merrins; Mark A Herman; Jenny Tong; Jonathan Campbell; David D'Alessio
Journal:  JCI Insight       Date:  2019-03-21

3.  Acute improvement in insulin resistance after laparoscopic Roux-en-Y gastric bypass: is 3 days enough to correct insulin metabolism?

Authors:  Gil Faria; John Preto; Eduardo Lima da Costa; João Tiago Guimarães; Conceição Calhau; António Taveira-Gomes
Journal:  Obes Surg       Date:  2013-01       Impact factor: 4.129

4.  The Effects of Bariatric Surgery on Islet Function, Insulin Secretion, and Glucose Control.

Authors:  Jonathan D Douros; Jenny Tong; David A D'Alessio
Journal:  Endocr Rev       Date:  2019-10-01       Impact factor: 19.871

Review 5.  Effects of bariatric surgery on glucose homeostasis and type 2 diabetes.

Authors:  David Bradley; Faidon Magkos; Samuel Klein
Journal:  Gastroenterology       Date:  2012-08-08       Impact factor: 22.682

6.  Effects of RYGB on energy expenditure, appetite and glycaemic control: a randomized controlled clinical trial.

Authors:  J B Schmidt; S D Pedersen; N T Gregersen; L Vestergaard; M S Nielsen; C Ritz; S Madsbad; D Worm; D L Hansen; T R Clausen; J F Rehfeld; A Astrup; J J Holst; A Sjödin
Journal:  Int J Obes (Lond)       Date:  2013-08-25       Impact factor: 5.095

Review 7.  Commercial Very Low Energy Meal Replacements for Preoperative Weight Loss in Obese Patients: a Systematic Review.

Authors:  Lynda J Ross; Siobhan Wallin; Emma J Osland; Muhammed Ashraf Memon
Journal:  Obes Surg       Date:  2016-06       Impact factor: 4.129

8.  Liver ENPP1 protein increases with remission of type 2 diabetes after gastric bypass surgery.

Authors:  Vinko Besic; Richard S Stubbs; Mark T Hayes
Journal:  BMC Gastroenterol       Date:  2014-12-24       Impact factor: 3.067

9.  Gastric inhibitory polypeptide (GIP) is selectively decreased in the roux-limb of dietary obese mice after RYGB surgery.

Authors:  Jiaqiang Zhou; Zheng Hao; Nigel Irwin; Hans-Rudolf Berthoud; Jianping Ye
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

Review 10.  Can medical therapy mimic the clinical efficacy or physiological effects of bariatric surgery?

Authors:  A D Miras; C W le Roux
Journal:  Int J Obes (Lond)       Date:  2013-11-11       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.